Prof Christopher Goldring BSc, PhD

Lecturer Molecular and Clinical Pharmacology

    Research

    Research Grants

    Developing a collaborative resource for ChIP based analyses of cancer related transcriptional networks

    CANCER RESEARCH UK (UK)

    April 2012 - March 2013

    Vacation Scholarship. The role of the Nrf2-keap 1 pathway in regulation of chemoresistance.

    WELLCOME TRUST (UK)

    July 2008 - August 2008

    Regenerative Medicine Platform in Stem Cell Safety Science

    MEDICAL RESEARCH COUNCIL (MRC)

    June 2013 - March 2018

    Definition of the mechanisms that underlie the decrease in expression of the cytochrome P450s in primary hepatocytes.

    BIOTECHNOLOGY & BIOLOGICAL SCIENCE RESEARCH COUNCIL (BBSRC)

    June 2007 - December 2009

    Manipulation of the physiological and toxicological phenotype of human hepatocytes by targeting cellular differentiation and de-differentiation

    MEDICAL RESEARCH COUNCIL (MRC)

    October 2014 - September 2018

    Investigation of Inflammatory Signalling during Drug-induced Hepatotoxicity Background

    BRITISH TOXICOLOGY SOCIETY (UK)

    October 2007 - September 2010

    The chemical and molecular basis of the prevention of drug-induced liver injury by Nrf2.

    WELLCOME TRUST (UK)

    January 2007 - December 2009

    Pharmacogenetic and functional analysis of novel GSTP1 polymorphism.

    ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST (UK)

    May 2005 - January 2007

    Investigation of the role of Nrf2 in man

    WELLCOME TRUST (UK)

    October 2011 - May 2015

    Mechanism and effect of Chinese antioxidant herbs on phase II drug-metabolizing enzymes.

    ROYAL SOCIETY (CHARITABLE)

    July 2005 - October 2005

    Capacity building award in integrative mammalian biology

    BIOTECHNOLOGY & BIOLOGICAL SCIENCE RESEARCH COUNCIL (BBSRC)

    January 2007 - October 2015

    Biomedical Vacation Scholarships

    WELLCOME TRUST (UK)

    July 2010 - August 2010

    University of Liverpool Institutional Discipline Bridging.

    MEDICAL RESEARCH COUNCIL (MRC)

    October 2003 - October 2006

    Analysis of inter-individual variation in the inducibility of the antioxidant response by Nrf2: an important element in the defence against cancer.

    NORTH WEST CANCER RESEARCH FUND

    May 2005 - April 2006

    Hepatocyte Phenotype Project: Phase II proposal

    STEM CELLS FOR SAFER MEDICINES LTD (UK)

    May 2011 - May 2014